X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Sterling Biotech Fact Sheet, Sterling Biotech Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sterling Biotech Fact Sheet   (STEA)

Here is the latest financial fact sheet of Sterling Biotech. For more details, see the Sterling Biotech quarterly results and Sterling Biotech share price and chart.

STERLING BIOTECH Price History

Price Rs 3.4
Mkt Cap Rs m 936
Vol '000 52.7
P/E X -1.6
P/CF X -0.6
EPS (TTM) Rs -2.1
% ch % 0.3
No. of shares m 272.05
% ch week % -7.0
% ch 1-mth % -14.9
% ch 12-mth % -20.9
52 week H/L Rs 6.8/3.1
(As on Feb 23, 2018 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

STERLING BIOTECH Financials

No. of Mths
Year Ending
12
Dec-09
12
Dec-10
12
Dec-11
12
Dec-12
12
Dec-13
5-Yr Chart
Click to enlarge
STERLING BIOTECH EQUITY SHARE DATA
High Rs1701261072011 
Low Rs90902153 
Sales per share (Unadj.) Rs57.560.362.031.226.8 
Earnings per share (Unadj.) Rs9.55.50.7-13.1-15.0 
Diluted earnings per shareRs8.75.40.7-12.9-14.7 
Cash flow per share (Unadj.) Rs14.412.810.2-3.4-5.5 
Dividends per share (Unadj.) Rs0.500.50000 
Adj. dividends per shareRs0.460.490.000.000.00 
Dividend yield (eoy) %0.40.5000 
Book value per share (Unadj.) Rs82.292.093.069.854.9 
Adj. book value per shareRs75.690.691.668.854.0 
Shares outstanding (eoy) m250.20267.87267.87267.87267.87 
Bonus/Rights/Conversions  BCBC--- 
Price / Sales ratio x2.31.81.00.40.3 
Avg P/E ratio x13.719.886.0-1.0-0.5 
P/CF ratio (eoy) x9.08.46.3-3.7-1.3 
Price / Book Value ratio x1.61.20.70.20.1 
Dividend payout %5.39.2000 
Avg Mkt Cap Rs m32,52628,93017,1573,3751,862 
No. of employees `000NANANA1.41.4 
Total wages/salary Rs m402437506537547 
Avg. sales/employee Rs ThNMNMNM6,049.15,303.3 
Avg. wages/employee Rs ThNMNMNM389.0403.8 
Avg. net profit/employee Rs ThNMNMNM-2,534.6-2,959.0 
STERLING BIOTECH INCOME DATA
Net Sales Rs m14,38216,16616,6208,3487,181 
Other income Rs m89106937043 
Total revenues Rs m14,47016,27216,7138,4187,223 
Gross profit Rs m5,0556,9716,3741,476947 
Depreciation Rs m1,2301,9762,5222,5882,543 
Interest Rs m1,4942,3052,7044,1234,377 
Profit before tax Rs m2,4192,7961,241-5,165-5,931 
Minority Interest Rs m00000 
Prior Period Items Rs m179800 
Extraordinary Inc (Exp) Rs m621-631-962-120 
Tax Rs m68671287-1,680-1,924 
Profit after tax Rs m2,3701,462200-3,498-4,007 
Gross profit margin %35.243.138.417.713.2 
Effective tax rate %28.425.57.032.532.4 
Net profit margin %16.59.01.2-41.9-55.8 
STERLING BIOTECH BALANCE SHEET DATA
Current assets Rs m18,51021,69821,81915,22214,335 
Current liabilities Rs m13,28812,55828,22339,28749,809 
Net working cap to sales %36.356.5-38.5-288.3-494.0 
Current ratio x1.41.70.80.40.3 
Inventory Days Days143155222380403 
Debtors Days Days150153159152171 
Net fixed assets Rs m34,00541,07745,87651,84955,432 
Share capital Rs m250268268268268 
"Free" reserves Rs m20,23924,12024,25017,94213,935 
Net worth Rs m20,56424,64924,90918,70814,701 
Long term debt Rs m18,60126,09015,06511,3749,478 
Total assets Rs m55,26266,41471,34570,83773,988 
Interest coverage x2.62.21.5-0.3-0.4 
Debt to equity ratio x0.91.10.60.60.6 
Sales to assets ratio x0.30.20.20.10.1 
Return on assets %7.05.74.10.90.5 
Return on equity %11.55.90.8-18.7-27.3 
Return on capital %11.68.87.5-3.5-6.4 
Exports to sales %31.631.130.926.725.9 
Imports to sales %0.40.30.50.10.2 
Exports (fob) Rs m4,5385,0355,1412,2301,860 
Imports (cif) Rs m545582412 
Fx inflow Rs m4,5385,0355,1412,2301,860 
Fx outflow Rs m708417710825 
Net fx Rs m4,4684,9514,9642,1221,835 
STERLING BIOTECH CASH FLOW
From Operations Rs m -13 3,482 3,697 8,113 1,719 
From Investments Rs m -4,213 -9,940 -7,332 -8,116 -3,148 
From Financial Activity Rs m 4,495 6,749 2,271 -38 1,426 
Net Cashflow Rs m 269 291 -1,364 -42 -3 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 33.9%
Foreign collaborators 0.0%
Indian inst/Mut Fund 0.0%
FIIs 9.9%
ADR/GDR 16.9%
Free float 39.3%
Shareholders 21,482
Pledged promoter(s) holding 55.9%
 

Company Information

REGD OFF 43, Atlanta Building, Nariman Point, Mumbai - 400 021
E-MAIL investorscomplain@stergel.com WEB www.sterlingbiopharma.com
TELEPHONE (022) 6630 6732 FAX (022) 2204 1954
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, C13, Pannalal Silk Mills Compd., LBS Marg, Mumbai-78
AUDITOR H. S. Hathi & Co.
CHM: Nitin J. Sandesara (MD) COMP SEC: Megha Chokshi YEAR OF INC: 1900 BSE CODE: 512299 FV (Rs): 1 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   SANWARIA AGRO OILS  RALLIS  INDIA GLYCOLS  THIRUMALAI CHEMICALS  PHILLIPS CARBON BLACK  

Compare STERLING BIOTECH With:   SANWARIA AGRO OILS  RALLIS  INDIA GLYCOLS  THIRUMALAI CHEMICALS  PHILLIPS CARBON BLACK  



Today's Market

Global Stock Markets Chart Modest Gains(RoundUp)

Global financial markets ended the holiday shortened week with modest gains. The rally put behind days of decline as concerns regarding swift interest rates hikes were put to ease.

Views on news

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 8-QTR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS